Nothing Special   »   [go: up one dir, main page]

KR100448098B1 - Resin composition of polyurethane hardening by moisture and cast for orthopedic surgery prepared therefrom - Google Patents

Resin composition of polyurethane hardening by moisture and cast for orthopedic surgery prepared therefrom Download PDF

Info

Publication number
KR100448098B1
KR100448098B1 KR10-2002-0001873A KR20020001873A KR100448098B1 KR 100448098 B1 KR100448098 B1 KR 100448098B1 KR 20020001873 A KR20020001873 A KR 20020001873A KR 100448098 B1 KR100448098 B1 KR 100448098B1
Authority
KR
South Korea
Prior art keywords
weight
moisture
resin composition
parts
cast
Prior art date
Application number
KR10-2002-0001873A
Other languages
Korean (ko)
Other versions
KR20030061875A (en
Inventor
이종헌
신천식
안영원
Original Assignee
이종헌
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이종헌 filed Critical 이종헌
Priority to KR10-2002-0001873A priority Critical patent/KR100448098B1/en
Publication of KR20030061875A publication Critical patent/KR20030061875A/en
Application granted granted Critical
Publication of KR100448098B1 publication Critical patent/KR100448098B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/04Plaster of Paris bandages; Other stiffening bandages
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/10Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/48Polyethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72Polyisocyanates or polyisothiocyanates
    • C08G18/74Polyisocyanates or polyisothiocyanates cyclic
    • C08G18/76Polyisocyanates or polyisothiocyanates cyclic aromatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)

Abstract

본 발명은 수분 경화성 폴리우레탄 수지 조성물에 관한 것으로, 구체적으로는 전체 조성물을 기준으로 하여 32∼42중량%의 폴리에테르 폴리올, 상기 폴리에테르 폴리올 및 방향족 폴리이소시아네이트로 이루어지는 혼합물을 기준으로 하여 50∼70중량%의 방향족 폴리이소시아네이트, 상기 폴리에테르 폴리올 및 방향족 폴리이소시아네이트로 이루어지는 혼합물 100중량부에 대하여 4.5∼6.5중량부의 액상 파라핀 및 5.0∼8.0중량부의 하이드로카본 겔을 포함하여 이루어지는 것을 특징으로 한다. 본 발명은 또한, 상기 조성물로부터 제조되는 정형외과용 캐스트에 관한 것이다.The present invention relates to a moisture-curable polyurethane resin composition, specifically from 50 to 70 based on a mixture of 32 to 42% by weight of a polyether polyol, the polyether polyol and an aromatic polyisocyanate based on the total composition. It is characterized by comprising 4.5 to 6.5 parts by weight of liquid paraffin and 5.0 to 8.0 parts by weight of hydrocarbon gel with respect to 100 parts by weight of the mixture consisting of weight% of aromatic polyisocyanate, the polyether polyol and aromatic polyisocyanate. The present invention also relates to an orthopedic cast prepared from the composition.

Description

수분 경화성 폴리우레탄 수지 조성물 및 그로부터 제조되는 정형외과용 캐스트{RESIN COMPOSITION OF POLYURETHANE HARDENING BY MOISTURE AND CAST FOR ORTHOPEDIC SURGERY PREPARED THEREFROM}RESIN COMPOSITION OF POLYURETHANE HARDENING BY MOISTURE AND CAST FOR ORTHOPEDIC SURGERY PREPARED THEREFROM}

본 발명은 수분 경화성 폴리우레탄 수지 조성물 및 이를 기질에 피복하여 성형함으로써 제조되는 정형외과용 캐스트에 관한 것이다.The present invention relates to a moisture-curable polyurethane resin composition and an orthopedic cast produced by coating and molding the substrate on a substrate.

정형 외과용 캐스트로 종래에는 석고로 만든 석고 붕대를 사용하였으나, 무게가 무거워 환자에 부담을 줄뿐만 아니라 공기가 투과하지 않아 살갗이 물르는 현상이 생겼다. 또한, X-ray가 투과하지 않는 등 여러 가지 문제점을 갖고 있어 최근에는 수분 경화성 합성 수지를 사용하고 있다.Conventionally, orthopedic casts used a gypsum bandage made of gypsum, but the weight was heavy, which not only burdened the patient but also caused the skin to bite as air did not penetrate. In addition, X-rays do not penetrate and have various problems. Recently, a moisture curable synthetic resin is used.

현재까지 외과용에 사용할 수 있는 캐스트 조성물이 연구 개발되고 있으며,이와 같은 캐스트는 다음과 같은 조건을 충족시켜야 한다.To date, cast compositions that can be used for surgery have been researched and developed, and such casts must meet the following conditions.

첫째, X-레이 촬영시에 캐스트에 의해 방해가 일어나서는 아니되며, 둘째, 단시간에 경화되어야 하며, 셋째, 경화시 높은 발열이 일어나 피부에 손상을 주어서는 아니되며, 넷째, 공기 투과성이 양호하여 땀이나 이물질의 배출이 용이하여 병균의 번식을 막아 주어야 하며, 다섯째, 가벼워 환자의 활동을 용이하게 하나 충분한 강도를 유지하여야 하며, 여섯째, 충분한 저장 안정성을 가져야 하며 마지막으로 인체에 무해하여야 한다.First, X-rays should not be disturbed by casts, secondly, it should be cured in a short time, and third, high heat generation during curing should not damage the skin. Fourth, air permeability is good. It should be easy to discharge sweat or foreign materials to prevent germs from propagating. Fifth, it should be light enough to facilitate the patient's activity but maintain sufficient strength. Sixth, it should have sufficient storage stability and finally harmless to human body.

현재까지 사용된 석고 캐스트는 강도는 뛰어나나 무게가 무겁고, 공기의 유통이 안되어 미생물의 번식이 용이할뿐만 아니라 X-레이 촬영에 부적합하는 등 많은 단점을 가지고 있다.Gypsum casts used up to now have a number of disadvantages such as high strength, heavy weight, poor air circulation, not only easy propagation of microorganisms, but also unsuitable for X-ray imaging.

상기한 석고의 문제점을 보완하기 위하여 폴리머를 함침한 그라스 화이버 수지에 수분으로 폴리머를 경화시켜 정형외과용 캐스팅 테이프에 이용하는 기술이 개발되어 있다.In order to supplement the above problems of gypsum, a technique has been developed for hardening the polymer with moisture in a glass fiber impregnated with a polymer and using it in an orthopedic casting tape.

가장 대표적인 폴리머로서는 폴리우레탄 수지를 많이 사용하고 있는데 이와 같이 폴리우레탄을 사용하는 기술은 독일 특허 공개 제2,353,212호, 영국 특허 제1,578,895호, 미국 특허 제4,376,438호 및 국제 공개 특허 제WO 81/00671호에 개시되어 있다. 또한, 저장 안정성을 갖기 위해 폴리우레탄 캐스트를 사용하면서 부반응을 억제하기 위해 미국 특허 제4,433,680호에서는 촉매로서 디모르포리노 디에틸 에테르를 사용하는 기술이 소개되어 있다. 안정화제를 첨가하는 기술이 미국 특허 제4,433,680호 및 제4,574,793호에 기재되어 있다. 미국특허 제4,667,661호에서는 윤활성을 개선하기 위한 방법으로서 수분 경화성 수지 내에 다수의 친수성기를 갖는 폴리에틸렌 폴리올류, 폴리실록산 또는 친수성 계면활성제를 사용하였다. 미국 특허 제4,397,146호에서는 윤활성을 개선하기 위해 미네랄 오일 등의 친유성 물질을 윤활제로 사용하는 기술이 소개되어 있다. 그러나, 이런 친유성 윤활제를 사용할 경우에는 캐스팅 테이프를 경화시키기 위해 물에 함침을 할 경우에는 그 친유성 윤활제의 특성으로 캐스팅 테이프 표면에 결로 현상이 일어난다. 따라서, 시술 시에 환자에게 불편한 감을 줄뿐만 아니라 미생물이 번식하는데 좋은 조건을 주게된다.Polyurethane resins are used as the most representative polymers. Polyurethane resins are used in German Patent Publication Nos. 2,353,212, UK Patent No. 1,578,895, US Patent No. 4,376,438, and WO 81/00671. Is disclosed. In addition, US Pat. No. 4,433,680 discloses the use of dimorpholino diethyl ether as a catalyst to suppress side reactions while using polyurethane casts to have storage stability. Techniques for adding stabilizers are described in US Pat. Nos. 4,433,680 and 4,574,793. In US Pat. No. 4,667,661, polyethylene polyols, polysiloxanes or hydrophilic surfactants having a plurality of hydrophilic groups in a moisture curable resin have been used as a method for improving lubricity. U.S. Patent No. 4,397,146 introduces the use of lipophilic substances such as mineral oils as lubricants to improve lubricity. However, when such a lipophilic lubricant is used, when water is impregnated to harden the casting tape, condensation occurs on the surface of the casting tape due to the characteristics of the lipophilic lubricant. Therefore, not only the patient feels uncomfortable during the procedure, but also gives a good condition for the growth of microorganisms.

상기와 같은 종래 기술의 문제점을 해결하기 위하여, 본 발명에서는 액상 파라핀을 사용하여 윤활성을 개선하고, 또한 하이드로 겔 타입의 보습성을 부여하는 물질을 폴리우레탄 예비 중합체에 사용함으로써 윤활성을 향상 시켜줌과 동시에 보습성이 뛰어난 수분 경화성 폴리우레탄 수지 조성물을 제공하는 것을 그 목적으로 한다.In order to solve the problems of the prior art as described above, the present invention improves lubricity by using a liquid paraffin to improve lubricity, and also by using a hydrogel type moisturizing substance in the polyurethane prepolymer, It is an object to provide a moisture curable polyurethane resin composition excellent in moisture retention properties.

또한, 본 발명은 보습제가 사용된 본 발명의 조성물을 이용함으로써 수분의 침강을 막을 수 있는 외과용 캐스트를 제공하는 것을 그 목적으로 한다.It is also an object of the present invention to provide a surgical cast which can prevent the sedimentation of moisture by using the composition of the present invention in which a moisturizing agent is used.

본 발명의 수분 경화성 폴리우레탄 수지 조성물은 전체 조성물을 기준으로 하여 32∼42중량%의 폴리에테르 폴리올, 상기 폴리에테르 폴리올 및 방향족 폴리이소시아네이트로 이루어지는 혼합물을 기준으로 하여 50∼70중량%의 방향족 폴리이소시아네이트, 상기 폴리에테르 폴리올 및 방향족 폴리이소시아네이트로 이루어지는 혼합물 100중량부에 대하여 4.5∼6.5중량부의 액상 파라핀 및 5.0∼8.0중량부의 하이드로카본 겔을 포함하여 이루어지는 것을 특징으로 한다.The water-curable polyurethane resin composition of the present invention comprises 50-70% by weight of aromatic polyisocyanate based on a mixture of 32-42% by weight of polyether polyol, the polyether polyol and aromatic polyisocyanate based on the total composition. And 4.5 to 6.5 parts by weight of liquid paraffin and 5.0 to 8.0 parts by weight of hydrocarbon gel with respect to 100 parts by weight of the mixture consisting of the polyether polyol and the aromatic polyisocyanate.

본 발명은 또한 정형외과용 캐스트에 관한 것으로, 상기의 수분 경화성 폴리우레탄 수지 조성물을 기질에 피복하여 성형함으로써 제조되는 것을 특징으로 한다.The present invention also relates to an orthopedic cast, characterized in that it is produced by coating the above moisture-curable polyurethane resin composition on a substrate and molding.

이하 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 수분 경화성 폴리우레탄 수지 조성물에 있어서, 상기 폴리에테르 폴리올 성분은 다관능성기를 가지는 고분자량과 저분자량 폴리에테르 폴리올로 구성하는 것이, 유연성과 가교성을 일정 비율로 유지시켜 적당한 물성을 가지게 하는데 바람직하다. 이때 고분자량과 저분자량 폴리에테르 폴리올의 혼합 비율은, 전체 폴리에테르 폴리올 성분 중 고분자량 폴리에테르 폴리올은 50∼65중량%이고, 저분자량 폴리에테르 폴리올은 35∼50중량%인 것이 바람직하다.In the moisture-curable polyurethane resin composition of the present invention, the polyether polyol component is composed of a high molecular weight and a low molecular weight polyether polyol having a polyfunctional group, so that the flexibility and the crosslinkability can be maintained at a constant ratio to have appropriate physical properties. It is desirable to. At this time, it is preferable that the mixing ratio of high molecular weight and a low molecular weight polyether polyol is 50 to 65 weight% of high molecular weight polyether polyol among all the polyether polyol components, and 35 to 50 weight% of low molecular weight polyether polyol.

폴리에테르 폴리올의 함량은 전체 조성물을 기준으로 하여 32∼42중량% 포함하는 것이 바람직하다. 그 함량이 32중량% 미만인 경우, 예비 중합체의 점도가 낮아 캐스트를 장기 보관시 수지가 흘러내리며 또한 캐스트의 강도가 떨어지게 된다, 42중량%를 초과하는 경우, 그 반대로 점도가 높아 캐스트의 풀림성에 문제를 야기하며 또한 저장 안정성에도 문제를 일으킨다.The content of the polyether polyol is preferably included 32 to 42% by weight based on the total composition. If the content is less than 32% by weight, the viscosity of the prepolymer is low, so that the resin flows during long-term storage of the cast, and the strength of the cast decreases. If the content is more than 42% by weight, the viscosity is high, and conversely, the looseness of the cast is problematic. And problems with storage stability.

본 발명의 수분 경화성 폴리우레탄 수지 조성물에 있어서, 상기 방향족 폴리 이소시아네이트는 예를 들면, 2,4-톨루엔 디이소시아네이트, 2,6-톨루엔 디이소시아네이트 또는 그 이성체의 혼합물, 4,4-디페닐메탄 디이소시아네이트 또는 그들의 혼합물과 같은 디이소시아네이트가 바람직하다. 또한, 미국 특허 제4,433,680호에 제시한 일반적인 액상-모노머릭 MDI(liquified MDI) 또는 순수 모노머릭 MDI를 사용할 수 있다. 상기 방향족 폴리 이소시아네이트 성분의 함량은, 폴리에테르 폴리올 및 방향족 폴리이소시아네이트로 이루어지는 혼합물을 기준으로 하여 50∼70중량%로 포함되는 것이 바람직하다. 그 함량이 50중량% 미만인 경우, 고점도가 되어 사용하기에 용이하지 않게 되는 문제점이 있고, 70중량%를 초과하는 경우 점도가 너무 낮아지게 되어 수지의 접착성에 문제를 야기시킨다. 또한, 방향족 디이소시아네이트 과다로 인한 안전성에도 문제가 있다.In the moisture-curable polyurethane resin composition of the present invention, the aromatic polyisocyanate is, for example, 2,4-toluene diisocyanate, 2,6-toluene diisocyanate or a mixture of isomers thereof, and 4,4-diphenylmethane di Preference is given to diisocyanates such as isocyanates or mixtures thereof. In addition, general liquid-monomeric MDIs or pure monomeric MDIs as described in US Pat. No. 4,433,680 may be used. It is preferable that content of the said aromatic polyisocyanate component is contained in 50 to 70 weight% based on the mixture which consists of a polyether polyol and aromatic polyisocyanate. If the content is less than 50% by weight, there is a problem that the high viscosity is not easy to use, when it exceeds 70% by weight the viscosity is too low causing problems in the adhesiveness of the resin. In addition, there is a problem in safety due to excessive aromatic diisocyanate.

이러한 상기 폴리에테르 폴리올 및 방향족 폴리이소시아네이트 성분은 중합되어 예비 중합체를 형성한다.These polyether polyols and aromatic polyisocyanate components are polymerized to form prepolymers.

또한, 본 발명의 조성물에는 상기 폴리에테르 폴리올 및 방향족 폴리이소시아네이트로 이루어지는 혼합물 100중량부에 대하여 4.5∼6.5중량부의 윤활제가 포함된다. 상기 윤활제는 액상 파라핀이 바람직하다. 상기 윤활제의 함량이 4.5중량부 미만인 경우, 충분한 윤활성을 주지 못하여 요구되는 작업성을 갖지 못하며, 6.5중량부를 초과하는 경우, 수지의 접착성이 현저히 떨어지며 또한 점도가 낮아져 장기 보관시 수지가 흘러내린다.In addition, the composition of the present invention contains 4.5 to 6.5 parts by weight of lubricant based on 100 parts by weight of the mixture consisting of the polyether polyol and the aromatic polyisocyanate. The lubricant is preferably liquid paraffin. When the content of the lubricant is less than 4.5 parts by weight, it does not give sufficient lubricity and does not have the required workability. When the amount of the lubricant exceeds 6.5 parts by weight, the adhesiveness of the resin is significantly lowered and the viscosity is lowered, so that the resin flows during long-term storage.

또한, 본 발명의 조성물에는 상기 폴리에테르 폴리올 및 방향족 폴리이소시아네이트로 이루어지는 혼합물 100중량부에 대하여 5.0∼8.0중량부의 보습제를 포함한다. 상기 보습제로는 하이드로카본 겔이 바람직하다. 본 발명에서 사용된 상기 친유성 윤활제는, 캐스팅 테이프를 경화시키기 위해 물에 함침할 경우, 그 친유성 윤활제의 특성으로 인하여 캐스팅 테이프 표면에 결로 현상을 일으킨다. 따라서, 시술 시에 환자에게 불편한 감을 줄뿐만 아니라 미생물이 번식하는데 좋은 조건을 주게 되는데, 상기 보습제, 바람직하기로는 상기 하이드로카본 겔은 이러한 결로 현상을 현저히 막아주는 역할을 한다.Furthermore, the composition of this invention contains 5.0-8.0 weight part moisturizer with respect to 100 weight part of mixtures which consist of the said polyether polyol and aromatic polyisocyanate. The moisturizing agent is preferably a hydrocarbon gel. The lipophilic lubricant used in the present invention, when impregnated with water to cure the casting tape, causes condensation on the surface of the casting tape due to the properties of the lipophilic lubricant. Therefore, in addition to giving the patient an uncomfortable feeling at the time of treatment, the microorganisms give good conditions for propagation. The moisturizing agent, preferably the hydrocarbon gel, plays a role in preventing such condensation.

본 발명의 조성물에는 상기한 성분외에 폴리우레탄 조성물 업계에서 통상적으로 사용되는 여러가지 성분이 사용될 수 있다. 예를 들면, 저장 안정제로는 일반적으로 사용되어지는 인산계 화합물을 소량 사용할 수 있다. 또한, 소포제 및 UV 안정제 등이 사용될 수 있다.In addition to the components described above, various compositions commonly used in the polyurethane composition industry may be used in the composition of the present invention. For example, a small amount of a phosphoric acid compound generally used may be used as the storage stabilizer. In addition, antifoaming agents and UV stabilizers may be used.

또한, 본 발명의 조성물에는 상기 폴리에테르 폴리올과 방향족 폴리이소시아네이트의 예비중합을 위하여 이미 공지된 것을 비롯하여 다양한 종류의 촉매를 사용할 수 있다. 바람직하기로는, 디몰포리노에틸에테르(DMDEE)를 사용하는 것이다. 그 함량은 수지 전체 성분에 대하여 1.0~1.9중량부가 바람직한데, 촉매의 사용량이 1.0중량부 미만이면 경화시간이 너무 느린 문제가 있고, 1.9중량부를 초과하면 너무 빠르게 경화되어 작업성에 문제가 있으며, 장기간의 저장 안정성이 낮게 되는 문제가 있다.In addition, various kinds of catalysts may be used in the composition of the present invention, including those already known for prepolymerization of the polyether polyol and aromatic polyisocyanate. Preferably, dimorpholinoethyl ether (DMDEE) is used. The content of the resin is preferably 1.0 to 1.9 parts by weight based on the total resin components. If the amount of the catalyst is less than 1.0 parts by weight, the curing time is too slow. If the content is more than 1.9 parts by weight, the curing time is too fast. Has a problem of low storage stability.

본 발명의 정형외과용 캐스트는 다음과 같은 중합과정에 의하여 제조된다. 먼저, 상기 본 발명의 조성물의 성분을 통상의 중합 방법을 이용하여 중합시켜 예비중합체를 합성한다. 합성 순서는 히터, 교반기, 건조 공기 사입기를 장착한 합성 용기에 디페닐메탄디이소시아네이트 또는 톨루엔 디이소시아네이트 등의 이소시아네이트류를 사입한 다음, 온도를 55∼60℃로 올린 후 상기한 폴리에테르 폴리올, 소포제, UV 안정제, 저장 안정제 및 액상 파라핀의 혼합물을 충분히 교반하면서 반응 용기에 서서히 사입하면서 반응시킨다. 반응은 발열 반응으로써 온도가 90℃가 넘지 않도록 조절한다. 반응이 종료되었음은 그 말단의 NCO %를 검사하여 종료를 결정하며, 검사는 통상의 NCO % 측정법을 사용한다. 종료 시점은 NCO %가12.5∼14.5%에 이르렀을 때 종료한다.Orthopedic cast of the present invention is prepared by the following polymerization process. First, the components of the composition of the present invention are polymerized using a conventional polymerization method to synthesize a prepolymer. Synthesis procedure was carried out by inserting isocyanates such as diphenylmethane diisocyanate or toluene diisocyanate into a synthesis vessel equipped with a heater, a stirrer, and a dry air injector, and then raising the temperature to 55 to 60 ° C., followed by the aforementioned polyether polyol and antifoaming agent. The mixture of the UV stabilizer, the storage stabilizer, and the liquid paraffin is reacted while slowly injected into the reaction vessel with sufficient stirring. The reaction is exothermic and controlled so that the temperature does not exceed 90 ° C. The completion of the reaction is determined by examining the NCO% at its end, and the test uses the usual NCO% measurement. The end point ends when the NCO% reaches 12.5-14.5%.

다음으로, 필요한 촉매, 보습제, 칼라 페이스트를 섞어 이를 기질에 피복시키는데, 이때의 피복량은 기질 및 수지의 전체량에 대하여 40∼60중량%로 한다. 본 발명에서 사용된 기질은 합성 섬유로 직조된 테이프 또는 부직포로 제조되어진 어떠한 것이든 사용 가능하지만, 특히 본 발명 폴리우레탄 수지 조성물에는 유리 섬유와 폴리 에스테르계 합성 섬유를 사용하는 것이 매우 우수한 물성을 가지게 된다.Next, the necessary catalyst, humectant, and color paste are mixed and coated on the substrate, wherein the coating amount is 40 to 60% by weight based on the total amount of the substrate and the resin. The substrate used in the present invention may be any one made of a tape or nonwoven fabric woven from synthetic fibers, but in particular, the polyurethane resin composition of the present invention may have excellent properties using glass fibers and polyester-based synthetic fibers. do.

본 발명의 정형외과용 캐스트는 테이프 형태로 얻어진다. 이때 본 발명의 캐스트는 저장안정성이 유지되도록 공기 및 수분으로 보호된 알루미늄 봉투에서 보관하고, 사용시 꺼내어 상온의 물속에 잠시 담근 후 골절 및 근육손상의 부위에 감고, 적절한 형태를 유지하기 위하여 손으로 문질러서 신체부위와 유사한 모양을 만들어 사용하게 된다.The orthopedic cast of the present invention is obtained in the form of a tape. At this time, the cast of the present invention is stored in an aluminum bag protected with air and moisture to maintain storage stability, taken out during use, soaked in water at room temperature for a while, wound around fractures and muscle injuries, and rubbed by hand to maintain an appropriate shape. It is used to make a shape similar to the body part.

실시예Example

이하 본 발명을 실시예를 통하여 상세하게 설명한다. 그러나, 이들 실시예는 본 발명을 예시적으로 설명하기 위한 목적으로 기술되는 것일뿐 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail through examples. However, these examples are only described for the purpose of illustrating the present invention by way of example, but the scope of the present invention is not limited to these examples.

본 실시예에 사용된 성분은 표1과 같으며, 그 물성 측정결과는 표2에 나타내었다.The components used in this example are shown in Table 1, and the measurement results of the physical properties are shown in Table 2.

실시예 1~8: 폴리우레탄 수지 조성물 제조Examples 1-8: Polyurethane Resin Composition

1ℓ 반응기에 질소를 주입시키면서 표1에 나타낸 방향족 디이소시아네이트성분을 투입하고 반응온도를 55~60℃로 유지시킨 다음, 표1에 나타낸 폴리에테르 폴리올 성분을 서서히 투입하되 온도가 90℃를 초과하지 않도록 하였다.While injecting nitrogen into the 1L reactor, the aromatic diisocyanate component shown in Table 1 was added and the reaction temperature was maintained at 55-60 ° C. Then, the polyether polyol component shown in Table 1 was slowly added, but the temperature did not exceed 90 ° C. It was.

모든 합성은 NCO %를 13.5%로 정하고 실시하였으며, 합성 후 측정하여 규정% 범위에서 ±0.5% 내에 들어올 때 완료된 것으로 하였다. 교반하면서 반응 온도를 상온까지 내리고, 상온에서 인산을 소량 투입하고 30분 동안 교반한 후 촉매로서 디몰포리노에틸에테르(DMDEE)를 전체 폴리우레탄 수지에 대하여 1.67중량부 투입하고 10분 동안 교반하였다. 그후 윤활제인 액상 파라핀인 KF-70(서진 화학 제품)을 폴리우레탄 수지 100중량부에 대하여 5.5중량부 투입하였다. 이어 하이드로카본 겔인 Versagel M-200(Penreco사 제품)을 6.2중량부 투입하고 교반하였다.All synthesis was carried out with a NCO% of 13.5%, and was measured after synthesis and completed when it came within ± 0.5% of the specified percentage range. After stirring, the reaction temperature was lowered to room temperature, a small amount of phosphoric acid was added at room temperature, and stirred for 30 minutes. Then, 1.67 parts by weight of dimorpholinoethyl ether (DMDEE) was added to the entire polyurethane resin as a catalyst, followed by stirring for 10 minutes. Thereafter, 5.5 parts by weight of KF-70 (Sujin Chemical Co., Ltd.), a liquid paraffin as a lubricant, was added to 100 parts by weight of the polyurethane resin. Subsequently, 6.2 parts by weight of a Versagel M-200 (manufactured by Penreco), a hydrocarbon gel, was added and stirred.

제조한 폴리우레탄 수지 조성물은 포장을 실시하고 1일 경과 후, 4인치(inch) 폭 유리섬유를 기질로 하고, 여기에 상기에서 제조한 폴리우레탄 수지 조성물을 함량 45%로 피복시킨 다음, 알루미늄 봉투에 밀봉 보관하였다.The prepared polyurethane resin composition was packaged with a 4 inch wide glass fiber as a substrate after 1 day of packaging, and the polyurethane resin composition prepared above was coated with a content of 45%, followed by an aluminum bag. Kept sealed.

비교예 1∼3Comparative Examples 1 to 3

1ℓ 반응기에 질소를 주입시키면서 표1에 나타낸 방향족 디이소시아네이트 성분을 투입하고 반응온도를 55~60℃로 유지시킨 다음, 표1에 나타낸 폴리에테르 폴리올 성분을 서서히 투입하되 온도가 90℃를 초과하지 않도록 하였다.While injecting nitrogen into the 1L reactor, the aromatic diisocyanate component shown in Table 1 was added and the reaction temperature was maintained at 55-60 ° C. Then, the polyether polyol component shown in Table 1 was slowly added but the temperature did not exceed 90 ° C. It was.

모든 합성은 NCO %를 13.5%로 정하고 실시하였으며, 합성 후 측정하여 규정% 범위에서 ±0.5% 내에 들어올 때 완료된 것으로 하였다. 교반하면서 반응 온도를 상온까지 내리고, 상온에서 인산을 소량 투입하고 30분간 교반한 후 촉매로서 디몰포리노에틸에테르(DMDEE)를 전체 폴리우레탄 수지에 대하여 1.67중량부 투입하고10분 동안 교반하였다. 그 이후 표1의 비교예에 있는 요구대로 선택적으로 윤활제인 액상 파라핀인 KF-70(서진 화학 제품)을 폴리우레탄 수지 100중량부에 대하여 5.5중량부 투입하였고, 다음으로 하이드로카본 겔인 Versagel M-200(Penreco사 제품)을 6.2중량부 투입하고 교반하였다.All synthesis was carried out with a NCO% of 13.5%, and was measured after synthesis and completed when it came within ± 0.5% of the specified percentage range. The reaction temperature was lowered to room temperature while stirring, a small amount of phosphoric acid was added at room temperature, and stirred for 30 minutes. Then, 1.67 parts by weight of dimorpholinoethyl ether (DMDEE) was added to the entire polyurethane resin as a catalyst, followed by stirring for 10 minutes. Thereafter, 5.5 parts by weight of liquid paraffin, KF-70 (Sujin Chemical), a lubricant, was optionally added to 100 parts by weight of polyurethane resin, as required in Comparative Example of Table 1. Next, Versagel M-200, a hydrocarbon gel, was added. 6.2 parts by weight of (manufactured by Penreco) was added and stirred.

제조한 폴리우레탄 수지 조성물은 포장을 실시하고 1일 경과 후, 4인치(inch) 폭 유리섬유를 기질로 하고, 여기에 상기에서 제조한 폴리우레탄 수지 조성물을 함량 45%로 피복시킨 다음, 알루미늄 봉투에 밀봉 보관하였다.The prepared polyurethane resin composition was packaged with a 4 inch wide glass fiber as a substrate after 1 day of packaging, and the polyurethane resin composition prepared above was coated with a content of 45%, followed by an aluminum bag. Kept sealed.

본 실시예에 사용된 측정방법Measurement method used in this example

(1) 압축 강도의 측정(1) measurement of compressive strength

상기 실시예의 캐스트 시트를 포장지에서 개봉하는 즉시 20∼25℃의 물에 넣고 꺼낸 후, 세게 흔들어 수분을 털어내었다.Immediately after opening the cast sheet of the above example in a wrapping paper, it was taken out in water at 20 to 25 ° C, and then shaken hard to shake off moisture.

캐스팅 시트를 펴면서 지름 5cm 원통에 6층(Layer)을 일정한 힘을 가하여 감는다. 이것을 대기중에서 24시간 보관한 후, 인장 측정기에서 압축강도를 시험하여 그 결과를 다음 표2에 나타내었다. 단, 인장 측정기의 속도는 5cm/min로 하고, 1cm 줄었을 때의 받는 하중값을 계산하였고, 단위는 kg/cm로 하여 3회 실시하여 평균을 계산하였다. 결과는 아래 표2에 나타내었다.While spreading out the casting sheet, a 6-layer cylinder is wound with a constant force on a 5cm diameter cylinder. After 24 hours of storage in air, the compressive strength was tested in a tensile tester and the results are shown in Table 2 below. However, the speed of the tension gauge was 5 cm / min, and the load value received when 1 cm was reduced was calculated, and the unit was kg / cm three times, and the average was calculated. The results are shown in Table 2 below.

(2) 윤활도 시험(2) lubricity test

상기 실시예의 캐스트 시트를 포장지에서 개봉하는 즉시 상대 습도가 1.0% 미만인 밀봉 함 속에서 10도로 기울인 경사로에 무게 200g, 지름 2.5cm인 쇠 구슬을 올려 놓은 후 30초 동안 미끌어지는 거리를 측정하여 표2에 나타내었다.As soon as the cast sheet of the above example was opened in a wrapping paper, a 200 g weight and a 2.5 cm diameter ball were placed on a ramp inclined at 10 degrees in a sealed box having a relative humidity of less than 1.0%, and then measured for a distance of sliding for 30 seconds. Shown in

(3) 점도 측정(3) viscosity measurement

상기 실시예에서 제조된 수지를 스핀들(spindle)이 #4인 Brookfield RVT 점도계를 사용하여 점도를 측정하였다. 측정 온도는 35℃이다. 결과를 표2에 나타내었다.The resin prepared in this example was measured for viscosity using a Brookfield RVT viscometer with spindle # 4. Measurement temperature is 35 degreeC. The results are shown in Table 2.

(4) 보습 실험(4) moisturizing experiment

상기 실시예의 캐스트 시트를 포장지를 제외한 수지 및 기질의 무게를 측정한 후, 캐스트를 포장지에서 개봉하는 즉시 10초 동안 20∼25℃의 물에 넣고 꺼낸 후 세게 흔들어 수분을 털어내었다. 즉시 무게를 측정하여 포함된 수분의 양을 측정한 후 실린더 형태의 캐스트를 5분 동안 기울여 떨어지는 수분의 양을 측정하여 토출되는 수분의 양을 적량하여 표2에 나타내었다.After measuring the weight of the resin and the substrate except the cast sheet of the wrapping paper, the cast was put out in water of 20-25 ℃ for 10 seconds immediately after opening the cast in the wrapping paper and shaken hard to shake off moisture. Immediately weighing the amount of water contained, and measuring the amount of water falling by tilting the cast in the form of a cylinder for 5 minutes, the amount of water discharged is shown in Table 2 appropriately.

표1. 각 실시예에 사용된 성분Table 1. Ingredients Used in Each Example

실시예Example 성분 및 사용량(g)Ingredients and Usage (g) 이소시아네이트Isocyanate 사용량usage 폴리에테르 폴리올Polyether polyols 사용량usage 윤활제slush 사용량usage 보습제Moisturizer 사용량usage 촉매catalyst 사용량usage 1One Isonate-143 LPIsonate-143 LP 63.563.5 PP-2000GP-400PP-2000GP-400 21.515.021.515.0 KF-70KF-70 5.55.5 Versagel M-200Versagel M-200 6.26.2 DMDEEDMDEE 1.671.67 22 Isonate-143 LPIsonate-143 LP 60.060.0 GP-3000PP-400GP-3000PP-400 35.015.035.015.0 KF-70KF-70 5.55.5 Versagel M-200Versagel M-200 6.26.2 DMDEEDMDEE 1.671.67 33 Isonate-143 LPIsonate-143 LP 58.058.0 GP-4000PP-750GP-4000PP-750 37.015.037.015.0 KF-70KF-70 5.55.5 Versagel M-200Versagel M-200 6.26.2 DMDEEDMDEE 1.671.67 44 Isonate-143 LPIsonate-143 LP 62.562.5 PP-3000GP-250PP-3000GP-250 25.012.525.012.5 KF-70KF-70 5.55.5 Versagel M-200Versagel M-200 6.26.2 DMDEEDMDEE 1.671.67 55 Isonate-143 LPIsonate-125 MKIsonate-143 LPIsonate-125 MK 33.530.033.530.0 PP-2000GP-400PP-2000GP-400 21.515.021.515.0 KF-70KF-70 5.55.5 Versagel M-200Versagel M-200 6.26.2 DMDEEDMDEE 1.671.67 66 Isonate-143 LPIsonate-125 MKIsonate-143 LPIsonate-125 MK 30.030.030.030.0 GP-3000PP-400GP-3000PP-400 35.015.035.015.0 KF-70KF-70 5.55.5 Versagel M-200Versagel M-200 6.26.2 DMDEEDMDEE 1.671.67 77 Isonate-143 LPIsonate-125 MKIsonate-143 LPIsonate-125 MK 30.028.030.028.0 GP-4000PP-750GP-4000PP-750 37.015.037.015.0 KF-70KF-70 5.55.5 Versagel M-200Versagel M-200 6.26.2 DMDEEDMDEE 1.671.67 88 Isonate-143 LPIsonate-125 MKIsonate-143 LPIsonate-125 MK 32.530.032.530.0 PP-3000GP-250PP-3000GP-250 25.012.525.012.5 KF-70KF-70 5.55.5 Versagel M-200Versagel M-200 6.26.2 DMDEEDMDEE 1.671.67 비교예1Comparative Example 1 Isonate-143 LPIsonate-143 LP 63.563.5 PP-2000GP-400PP-2000GP-400 21.515.021.515.0 KF-70KF-70 00 Versagel M-200Versagel M-200 00 DMDEEDMDEE 1.671.67 비교예2Comparative Example 2 Isonate-143 LPIsonate-143 LP 60.060.0 GP-3000PP-400GP-3000PP-400 35.015.035.015.0 KF-70KF-70 00 Versagel M-200Versagel M-200 6.26.2 DMDEEDMDEE 1.671.67 비교예3Comparative Example 3 Isonate-143 LPIsonate-143 LP 58.058.0 GP-4000PP-750GP-4000PP-750 37.015.037.015.0 KF-70KF-70 5.55.5 Versagel M-200Versagel M-200 00 DMDEEDMDEE 1.671.67

상기 표1에 기재한 성분외에 각각의 실시예에는, 소포제로 SAG-1000(Witco사 제품) 0.1%, UV 안정제로 ZICO A1(지코사 제품)을 0.2%, 안정제로 인산 0.1%를 첨가하였다.In addition to the components shown in Table 1, in each of the examples, 0.1% of SAG-1000 (manufactured by Witco) as an antifoaming agent, 0.2% of ZICO A1 (manufactured by Zico Corporation) as a UV stabilizer, and 0.1% phosphoric acid as the stabilizer were added.

표1 중에서 사용된 각 성분의 특성은 다음과 같다.The properties of each component used in Table 1 are as follows.

Isonate-143 LP: 액상 모노머릭 제품(Dow Chemical 제품)Isonate-143 LP: Liquid Monomeric Products (Dow Chemical Products)

Isonate-125 MK: 모노머릭 MDI(Dow Chemical 제품)Isonate-125 MK: Monomeric MDI (Dow Chemical product)

PP-2000: 한국폴리올 제품PP-2000: Korean Polyol Products

GP-400: 한국폴리올 제품GP-400: Korean Polyol Product

GP-3000: 한국폴리올 제품GP-3000: Korean Polyol Product

PP-400: 한국폴리올 제품PP-400: Korean Polyol Products

GP-4000: 한국폴리올 제품GP-4000: Korean Polyol Product

PP-750: 한국폴리올 제품PP-750: Korean Polyol Products

PP-3000: 한국폴리올 제품PP-3000: Korean Polyol Products

GP-250: 한국폴리올 제품GP-250: Korean Polyol Product

KF-70: 서진화학 제품KF-70: Seojin Chemicals

DMDEE: Nitroil사 제품DMDEE: from Nitroil

표2. 각 실시예의 캐스트용 시트의 물성 측정 결과Table 2. Physical property measurement result of the sheet for casting of each Example

실시예Example 물성Properties 압축강도(kgf)Compressive strength (kgf) 윤활도(℃m)Lubrication degree (℃ m) 점도(cps at 35℃)Viscosity (cps at 35 ℃) 보습성(%)Moisturizing (%) 1One 89.689.6 156.0156.0 38,00038,000 0.90.9 22 88.288.2 168.0168.0 32,00032,000 0.60.6 33 85.285.2 148.0148.0 31,00031,000 0.70.7 44 93.093.0 168.0168.0 28,00028,000 0.80.8 55 87.287.2 175.0175.0 36,00036,000 0.90.9 66 85.485.4 189.0189.0 42,00042,000 1.11.1 77 82.282.2 155.0155.0 43,00043,000 0.90.9 88 89.689.6 172.0172.0 39,00039,000 0.20.2 비교예1Comparative Example 1 88.888.8 32.032.0 35,00035,000 1.51.5 비교예2Comparative Example 2 90.290.2 24.024.0 32,00032,000 0.20.2 비교예3Comparative Example 3 89.089.0 168.0168.0 31,00031,000 7.27.2

본 발명의 조성물에 의하면, 폴리에테르 폴리올을 첨가하여 유연성과 가교성을 일정 비율로 유지시켜줌으로써 적당한 물성을 가지게 하며 수지의 점성 부분을 보완하고, 소수성인 액상 파라핀을 윤활제로 사용하여 뛰어난 윤활성을 부여할 수 있다.According to the composition of the present invention, by adding a polyether polyol to maintain a certain ratio of flexibility and crosslinking properties to have a proper physical properties, to complement the viscosity of the resin, to give excellent lubricity by using a hydrophobic liquid paraffin as a lubricant can do.

또한, 본 발명의 외과용 캐스트는 보습제가 사용된 본 발명의 조성물을 이용함으로써 수분의 침강을 막을 수 있다.In addition, the surgical cast of the present invention can prevent the sedimentation of moisture by using the composition of the present invention in which a moisturizing agent is used.

Claims (4)

전체 조성물을 기준으로 하여 32∼42중량%의 폴리에테르 폴리올, 상기 폴리에테르 폴리올 및 방향족 폴리이소시아네이트로 이루어지는 혼합물을 기준으로 하여 50∼70중량%의 방향족 폴리이소시아네이트, 상기 폴리에테르 폴리올 및 방향족 폴리이소시아네이트로 이루어지는 혼합물 100중량부에 대하여 4.5∼6.5중량부의 액상 파라핀 및 5.0∼8.0중량부의 하이드로카본 겔을 포함하여 이루어지는 것을 특징으로 하는 수분 경화성 폴리우레탄 수지 조성물.From 32 to 42% by weight of polyether polyols based on the total composition, from 50 to 70% by weight of aromatic polyisocyanates based on the mixture of said polyether polyols and aromatic polyisocyanates, said polyether polyols and aromatic polyisocyanates A water curable polyurethane resin composition comprising 4.5 to 6.5 parts by weight of liquid paraffin and 5.0 to 8.0 parts by weight of hydrocarbon gel with respect to 100 parts by weight of the mixture formed. 제1항에 있어서, 상기 방향족 폴리이소시아네이트는 디이소시아네이트인 것을 특징으로 하는 수분 경화성 폴리우레탄 수지 조성물.The moisture-curable polyurethane resin composition according to claim 1, wherein the aromatic polyisocyanate is diisocyanate. 제1항의 수분 경화성 폴리우레탄 수지 조성물을 기질에 피복하여 성형함으로써 제조되는 것을 특징으로 하는 정형외과용 캐스트.An orthopedic cast prepared by coating the moisture-curable polyurethane resin composition of claim 1 with a substrate and molding. 제3항에 있어서, 상기 기질은 유리 섬유 또는 폴리에스테르임을 특징으로 하는 정형외과용 캐스트.4. The orthopedic cast of claim 3, wherein the substrate is glass fiber or polyester.
KR10-2002-0001873A 2002-01-12 2002-01-12 Resin composition of polyurethane hardening by moisture and cast for orthopedic surgery prepared therefrom KR100448098B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2002-0001873A KR100448098B1 (en) 2002-01-12 2002-01-12 Resin composition of polyurethane hardening by moisture and cast for orthopedic surgery prepared therefrom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2002-0001873A KR100448098B1 (en) 2002-01-12 2002-01-12 Resin composition of polyurethane hardening by moisture and cast for orthopedic surgery prepared therefrom

Publications (2)

Publication Number Publication Date
KR20030061875A KR20030061875A (en) 2003-07-23
KR100448098B1 true KR100448098B1 (en) 2004-09-13

Family

ID=32217851

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2002-0001873A KR100448098B1 (en) 2002-01-12 2002-01-12 Resin composition of polyurethane hardening by moisture and cast for orthopedic surgery prepared therefrom

Country Status (1)

Country Link
KR (1) KR100448098B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7438697B2 (en) * 2005-09-26 2008-10-21 3M Innovative Properties Company Orthopedic cast system and method

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983064A (en) * 1973-10-10 1976-09-28 The Dow Chemical Company Solid, rapid-setting, rigid polyurethanes
US4013598A (en) * 1972-07-11 1977-03-22 Evans Robert M Composition and method for making seamless flooring and the like
US4533598A (en) * 1983-11-18 1985-08-06 Caschem, Inc. Extended polyurethanes
US4596725A (en) * 1984-05-04 1986-06-24 Henkel Kommanditgesellschaft Auf Aktien Polyurethane insulating foam
US6077925A (en) * 1997-08-26 2000-06-20 Shell Oil Company Structural adhesives
US6140452A (en) * 1994-05-06 2000-10-31 Advanced Bio Surfaces, Inc. Biomaterial for in situ tissue repair

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013598A (en) * 1972-07-11 1977-03-22 Evans Robert M Composition and method for making seamless flooring and the like
US3983064A (en) * 1973-10-10 1976-09-28 The Dow Chemical Company Solid, rapid-setting, rigid polyurethanes
US4533598A (en) * 1983-11-18 1985-08-06 Caschem, Inc. Extended polyurethanes
US4596725A (en) * 1984-05-04 1986-06-24 Henkel Kommanditgesellschaft Auf Aktien Polyurethane insulating foam
US6140452A (en) * 1994-05-06 2000-10-31 Advanced Bio Surfaces, Inc. Biomaterial for in situ tissue repair
US6077925A (en) * 1997-08-26 2000-06-20 Shell Oil Company Structural adhesives

Also Published As

Publication number Publication date
KR20030061875A (en) 2003-07-23

Similar Documents

Publication Publication Date Title
US8481801B2 (en) Fluid wound dressing comprising partially cured polyurethane
EP0086621B1 (en) Polyurethane casting material
US5266669A (en) Softening non-swelling polyurethane
JP3974942B2 (en) Hydrophilic and adhesive polyurethane gel composition
CA2157777A1 (en) Novel casting tapes and resins and processes therefor
EP0223380B1 (en) Reinforced casting material
EP0276117B1 (en) Reinforced casting material
JPS62270161A (en) Rapid curable bandage tape
GB2284353A (en) Water curable supporting bandage
KR100448098B1 (en) Resin composition of polyurethane hardening by moisture and cast for orthopedic surgery prepared therefrom
KR100249674B1 (en) A water-hardening polyureathane resin composition
KR100654425B1 (en) Hydrocurable polyurethane resin composition and semi-cast casting tape using the same
EP0266892B1 (en) Polyurethane casting tape
KR0167828B1 (en) Moisture Curable Polyurethane Resin Composition
WO2004037307A1 (en) Fluid wound dressing comprising partially cured polyurethane
KR100428748B1 (en) Water-setting polyurethane resin composition for casting tape
KR100428747B1 (en) Fast-setting polyurethane resin composition for casting tape
KR20000008609A (en) Moisture Curable Polyurethane Cast Composition
KR19980031089A (en) Manufacturing method of yellowing resistant casting tape
KR100981440B1 (en) Hydrosetting Polyurethane Resin and Hydrosetting Polyurethane Casting Sheet

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20020112

PA0201 Request for examination
PG1501 Laying open of application
E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20040531

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20040901

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20040901

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20070619

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20080811

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20091029

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20100802

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20110901

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20120831

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20120831

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20130731

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20130731

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20140901

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20140901

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20150630

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20150630

Start annual number: 12

End annual number: 12

PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20190604

FPAY Annual fee payment

Payment date: 20190604

Year of fee payment: 15

PR0401 Registration of restoration

Patent event code: PR04011E01D

Patent event date: 20190604

Comment text: Registration of Restoration

PR1001 Payment of annual fee

Payment date: 20190604

Start annual number: 15

End annual number: 15

R401 Registration of restoration
FPAY Annual fee payment

Payment date: 20190819

Year of fee payment: 16

PR1001 Payment of annual fee

Payment date: 20190819

Start annual number: 16

End annual number: 16

PR1001 Payment of annual fee

Payment date: 20200819

Start annual number: 17

End annual number: 17

PR1001 Payment of annual fee

Payment date: 20210630

Start annual number: 18

End annual number: 18

PC1801 Expiration of term

Termination date: 20220712

Termination category: Expiration of duration

Termination date: 20190604

Termination category: Default of registration fee